The effect of open-label semaglutide on metabolic dysfunction-associated steatotic liver disease in people with HIV
Written By
Lake JE, Kitch DW, Kantor A, Muthupillai R, Klingman KL, Vernon C, Belaunzaran-Zamudio PF, Fichtenbaum CJ, Heath S, Perazzo H, Corey K, Brown TT, Landay A, Sattler F, Erlandson KM
